These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 1614535)

  • 1. Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase.
    Kuo CJ; Chung J; Fiorentino DF; Flanagan WM; Blenis J; Crabtree GR
    Nature; 1992 Jul; 358(6381):70-3. PubMed ID: 1614535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of 70-kDa S6 kinase, induced by the cytokines interleukin-3 and erythropoietin and inhibited by rapamycin, is not an absolute requirement for cell proliferation.
    Calvo V; Wood M; Gjertson C; Vik T; Bierer BE
    Eur J Immunol; 1994 Nov; 24(11):2664-71. PubMed ID: 7957559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapamycin-sensitive phosphorylation of ribosomal protein S17 by p70 S6 kinase.
    Patel HR; Terada N; Gelfand EW
    Biochem Biophys Res Commun; 1996 Oct; 227(2):507-12. PubMed ID: 8878544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The rapamycin-sensitive signal transduction pathway as a target for cancer therapy.
    Hidalgo M; Rowinsky EK
    Oncogene; 2000 Dec; 19(56):6680-6. PubMed ID: 11426655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-linking CD28 leads to activation of 70-kDa S6 kinase.
    Pai SY; Calvo V; Wood M; Bierer BE
    Eur J Immunol; 1994 Oct; 24(10):2364-8. PubMed ID: 7523138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of p70 s6 kinase by kinase activity of FRAP in vivo.
    Brown EJ; Beal PA; Keith CT; Chen J; Shin TB; Schreiber SL
    Nature; 1995 Oct; 377(6548):441-6. PubMed ID: 7566123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. L-leucine availability regulates phosphatidylinositol 3-kinase, p70 S6 kinase and glycogen synthase kinase-3 activity in L6 muscle cells: evidence for the involvement of the mammalian target of rapamycin (mTOR) pathway in the L-leucine-induced up-regulation of system A amino acid transport.
    Peyrollier K; Hajduch E; Blair AS; Hyde R; Hundal HS
    Biochem J; 2000 Sep; 350 Pt 2(Pt 2):361-8. PubMed ID: 10947949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mammalian protein targeted by G1-arresting rapamycin-receptor complex.
    Brown EJ; Albers MW; Shin TB; Ichikawa K; Keith CT; Lane WS; Schreiber SL
    Nature; 1994 Jun; 369(6483):756-8. PubMed ID: 8008069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arginine and Leucine regulate p70 S6 kinase and 4E-BP1 in intestinal epithelial cells.
    Ban H; Shigemitsu K; Yamatsuji T; Haisa M; Nakajo T; Takaoka M; Nobuhisa T; Gunduz M; Tanaka N; Naomoto Y
    Int J Mol Med; 2004 Apr; 13(4):537-43. PubMed ID: 15010853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p70 S6 kinase sensitivity to rapamycin is eliminated by amino acid substitution of Thr229.
    Sugiyama H; Papst P; Gelfand EW; Terada N
    J Immunol; 1996 Jul; 157(2):656-60. PubMed ID: 8752914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases.
    Chung J; Kuo CJ; Crabtree GR; Blenis J
    Cell; 1992 Jun; 69(7):1227-36. PubMed ID: 1377606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of cell cycle progression by rapamycin induces T cell clonal anergy even in the presence of costimulation.
    Powell JD; Lerner CG; Schwartz RH
    J Immunol; 1999 Mar; 162(5):2775-84. PubMed ID: 10072524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mammalian target of rapamycin, a molecular target in squamous cell carcinomas of the head and neck.
    Amornphimoltham P; Patel V; Sodhi A; Nikitakis NG; Sauk JJ; Sausville EA; Molinolo AA; Gutkind JS
    Cancer Res; 2005 Nov; 65(21):9953-61. PubMed ID: 16267020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapamycin enhances apoptosis and increases sensitivity to cisplatin in vitro.
    Shi Y; Frankel A; Radvanyi LG; Penn LZ; Miller RG; Mills GB
    Cancer Res; 1995 May; 55(9):1982-8. PubMed ID: 7728769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S6 phosphorylation results from prothoracicotropic hormone stimulation of insect prothoracic glands: a role for S6 kinase.
    Song Q; Gilbert LI
    Dev Genet; 1994; 15(4):332-8. PubMed ID: 7923936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of action of the immunosuppressant rapamycin.
    Dumont FJ; Su Q
    Life Sci; 1996; 58(5):373-95. PubMed ID: 8594303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin 2 stimulation of p70 S6 kinase activity is inhibited by the immunosuppressant rapamycin.
    Calvo V; Crews CM; Vik TA; Bierer BE
    Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7571-5. PubMed ID: 1380162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapamycin-induced inhibition of the 70-kilodalton S6 protein kinase.
    Price DJ; Grove JR; Calvo V; Avruch J; Bierer BE
    Science; 1992 Aug; 257(5072):973-7. PubMed ID: 1380182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p70(s6k) integrates phosphatidylinositol 3-kinase and rapamycin-regulated signals for E2F regulation in T lymphocytes.
    Brennan P; Babbage JW; Thomas G; Cantrell D
    Mol Cell Biol; 1999 Jul; 19(7):4729-38. PubMed ID: 10373522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of human B lymphocyte cell cycle progression and differentiation by rapamycin.
    Aagaard-Tillery KM; Jelinek DF
    Cell Immunol; 1994 Jul; 156(2):493-507. PubMed ID: 7517796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.